Full-Time

Life Sciences Subject Matter Expert

Updated on 9/5/2026

Deadline 5/28/27
IPS-Integrated Project Services, LLC

IPS-Integrated Project Services, LLC

1,001-5,000 employees

Integrated design, engineering, construction management

No salary listed

Mumbai, Maharashtra, India + 2 more

More locations: Hyderabad, Telangana, India | New Delhi, Delhi, India

In Person

Primarily based in India, with support for APAC, EMEA, and US regions as required.

Bachelor's, Master's, PhD

Category
Consulting
Required Skills
Process Engineering
Word/Pages/Docs
Excel/Numbers/Sheets

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Requirements
  • 20+ years of process design experience within the pharmaceutical industry in high-potency active pharmaceutical ingredients or biotechnology.
  • A bachelor's degree from an accredited university or college in engineering or a relevant science.
  • Strong proficiency in office software, including Microsoft Word, Excel, and PowerPoint.
  • Good manufacturing practice design experience and knowledge of regulatory requirements of various international bodies.
  • General knowledge of system design and applicable codes in process engineering.
  • Proven experience interacting and communicating directly with clients and leading conceptual design efforts.
  • Demonstrated ability to manage projects, solve problems, communicate effectively with key personnel, manage time, and work on more than one project at a time.
Responsibilities
  • Maintain global exposure and stay current with new trends and future advancements in the field of expertise to bring best practices into project execution for high-potency active pharmaceutical ingredients and biotechnology.
  • Primarily support the India market, with flexibility to extend support to APAC, EMEA, and US regions as required.
  • Connect with IPS global subject-matter experts as needed and participate in the community of practice.
  • Lead the team in conceptual, front-end, and detailed engineering while providing process-engineering options and value additions to enhance project outcomes.
  • Establish contact with potential clients and obtain client history to develop client profiles.
  • Engage as a subject-matter expert to enhance IPS brand and client engagement, develop client and subcontractor relations, and promote IPS brand awareness.
  • Participate in events to promote business-development initiatives and seek new projects with existing or new clients.
  • Contribute to the preparation and delivery of strategic sales presentations and proposals for the Life Sciences region.
  • Coordinate with project-management teams and discipline directors to determine project scope, complexity, and requirements.
  • Define an appropriate, cost-effective workflow process and level of design detail to achieve project goals.
  • Ensure the quality, accuracy, consistency, and completeness of work in alignment with process architecture and process design principles and established IPS standards, procedures, codes, and ordinances.
  • Review productivity and quality reports regularly to ensure optimal performance.
  • Facilitate master planning, feasibility studies, and conceptual design for assigned projects.
  • Define design philosophies and facility design parameters for assigned special projects.
Desired Qualifications
  • A master's degree or Ph.D.
  • Active participation in industry organizations and related initiatives, such as speaking engagements and presentations at industry events and conferences.
IPS-Integrated Project Services, LLC

IPS-Integrated Project Services, LLC

View

IPS provides design, engineering, and construction management for complex facilities, especially in the pharmaceutical and biotech industries. Its products work by integrating these services into one team from the project’s start, coordinating planning, detailed design, procurement, and construction management to align with a client's business goals and move a project from concept to operational facility. The company differentiates itself through integrated delivery across disciplines and a global footprint (five continents), supported by growth through strategic acquisitions and Berkshire Hathaway backing, which adds financial strength and scale. IPS’s goal is to help life-science clients bring critical facilities online efficiently, with predictable cost, schedule, and quality, by delivering coordinated design, engineering, and construction management under one umbrella.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Philadelphia, Pennsylvania

Founded

1989

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • GE HealthCare named IPS lead on its Cork expansion on January 31, 2025.
  • BeiGene's $800 million Hopewell facility completed in January 2025, proving delivery at scale.
  • Revelio Labs showed 7,131 employees in March 2026, with 561 active postings across the business.

What critics are saying

  • Kinetic System v. IPS ended with adverse fee rulings on March 24, 2025, exposing contract friction.
  • IPS remains tied to capital-intensive drug plants; project cancellations quickly crush utilization and margin.
  • If biotech capex freezes through 2026, IPS loses backlog concentration and Berkshire owns a cyclical builder.

What makes IPS-Integrated Project Services, LLC unique

  • IPS integrates EPCMV across pharma and biotech, from concept through final process qualification.
  • Berkshire Hathaway ownership since 2022 gives IPS permanent capital and credibility with large customers.
  • IPS runs 29 offices across 22 countries, supporting global delivery for regulated facilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

12%

2 year growth

12%
PR Newswire
Aug 8th, 2025
AST Names Industry Veteran Jacob Stephen as Chief Operating Officer

TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ - AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company.

IPSDB
Mar 14th, 2025
IPS Expands Leadership in Ireland with Appointment of Karl Page

IPS expands leadership in Ireland with appointment of Karl Page.

HIT Consultant
Feb 25th, 2025
The Future Of Advanced Therapeutics: Opportunities And Challenges

Sai Bhamidipati, Pharmaceutical Regulatory Affairs ConsultantThe biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases. Yet, they also present unique regulatory and manufacturing challenges that must be navigated to bring them from the laboratory to the clinic.mRNA Vaccines: Revolutionizing Disease PreventionMessenger RNA (mRNA) vaccines have gained prominence, particularly during the COVID-19 pandemic, demonstrating the potential for rapid development and high efficacy. Unlike traditional vaccines, which utilize weakened or inactivated pathogens or their protein subunits, mRNA vaccines utilize a synthetic version of the messenger RNA to instruct cells to produce a protein that elicits an immune response. This modality allows for swift adaptation to emerging pathogens and has opened avenues for vaccines targeting various diseases, including influenza and certain types of cancers.Opportunities:Rapid Development: The cell-free, scalable nature of mRNA production enables quick responses to emerging health threats.IPSDBThe cell-free, scalable nature of mRNA production enables quick responses to emerging health threats. IPSDB Versatility: mRNA vaccines can be designed to target a wide range of therapeutic areas, including but not limited to infectious diseases, Cancer-specific antigens, and rare disease areas.Challenges:Manufacturing Complexities: Scaling up production for mass production while maintaining quality and consistency poses significant challenges

IPSDB
Sep 18th, 2024
Kneat and IPS Announce Strategic Partnership

By integrating Kneat's digital validation software with IPS' technology driven delivery approach, a new benchmark for a truly digital integrated project delivery model, from concept/requirements definition through final process qualification.

IPSDB
Jul 11th, 2024
IPS Accelerates Expansion in Switzerland with New Office and Enhanced R&D Capabilities

Additionally, Integrated Project Services, LLC is excited to announce the appointment of Pia Mueller as the new Senior Manager of Laboratory Projects.